v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net Loss $ (1,172,814) $ (6,945,370)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 1,586 1,480
Amortization of debt issuance costs 45,952 165,082
Stock-based compensation 153,000
Liquidated damages -warrants 710,375
Convertible note default penalty 146,054
Change in fair value of derivative liability (48,816) (115,296)
Loss on settlement of debt 33,510 3,824,936
Write-off of accounts receivable 50,000
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 35,424 (308,464)
Other assets 713
Accounts payable and accrued liabilities 155,520 651,120
Net change in operating right-of-use lease asset and liability (1,112)
Cash used in operating activities (188,550) (2,428,570)
Financing activities:    
Proceeds from issuance of common stock units 5,372,787
Deferred offering costs (24,375)
Proceeds from issuance of Series B Preferred stock 605,000
Repayment to related party payable (21,729)
Proceeds from notes payable 30,000
Repayment of notes payable (55,000)
Proceeds from convertible notes payable 260,000
Repayment of convertible notes payable (48,663) (802,984)
Cash provided by financing activities 189,608 5,125,428
Change in cash 1,058 2,696,858
Cash, beginning balances 281
Cash, ending balances 1,339 2,696,858
Supplemental cash flow information:    
Cash paid for interest 11,337 109,088
Cash paid for taxes
Non-Cash Investing and Financing Activities:    
Initial derivative liabilities recognized as a debt discount 50,000
Series C warrants issued 1,053,514
Issuance common stock for settlement of debt 167,798 286,808
Common stock issued for conversion of debt 7,657,990
Common stock issued for conversion of Series B Preferred Shares 69
Common stock issued for exercise of warrants $ 18,200 $ 892